Voltar
Artigo Revisado por pares
BIBTEX RIS

Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902

2014; Springer Science+Business Media; Volume: 74; Issue: 6 Linguagem: Inglês

10.1007/s00280-014-2589-3

ISSN

1432-0843

Autores

Kenya Kanazawa, Hiroshi Yokouchi, Xintao Wang, Takashi Ishida, Yuka Fujita, Satoru Fujiuchi, Toshiyuki Harada, Masao Harada, Kei Takamura, Satoshi Oizumi, Ichiro Kinoshita, Yutaka Katsuura, Osamu Honjo, Tetsuya Kojima, Hirotoshi Dosaka‐Akita, Hiroshi Isobe, Mitsuru Munakata, Masaharu Nishimura,

Tópico(s)

Lung Cancer Research Studies

Referência(s)